bioven mono 50 mg/1 ml rastvor za infuziju
doo ˝farmacija 2011˝ bihać - imunoglobulin, normalno humanitarne intravaskularnu primjenu doručak - rastvor za infuziju - 50 mg/1 ml - 1 ml rastvora za infuziju sadrži: 50 mg imunološki aktivne proteinske frakcije imunoglobulina g
darzalex (▼) 100 mg/5 ml koncentrat za rastvor za infuziju
inpharm co. d.o.o. banja luka - daratumumab - koncentrat za rastvor za infuziju - 100 mg/5 ml - 1 bočica od 5 ml koncentrata za rastvor za infuziju sadrži: 100 mg daratumumaba
darzalex (▼) 400 mg/20 ml koncentrat za rastvor za infuziju
inpharm co. d.o.o. banja luka - daratumumab - koncentrat za rastvor za infuziju - 400 mg/20 ml - 1staklena bočica od 20 ml koncentrata za rastvor za infuziju sadrži: 400 mg daratumumaba
darzalex 1800mg rastvor za injekciju
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - daratumumab - rastvor za injekciju - 1800mg
darzalex 20mg/ml koncentrat za rastvor za infuziju
druŠtvo sa ograniČenom odgovornoŠĆu "inpharm co" podgorica - daratumumab - koncentrat za rastvor za infuziju - 20mg/ml
darzalex 20mg/ml koncentrat za rastvor za infuziju
druŠtvo sa ograniČenom odgovornoŠĆu "inpharm co" podgorica - daratumumab - koncentrat za rastvor za infuziju - 20mg/ml
revolade
novartis europharm limited - eltrombopag - purpura, trombocitopenična, idiopatska - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
devapen 200000 i.j./1 bočica+ 600000 i.j./1 bočica prašak i rastvarač za rastvor za injekciju
unifarm d.o.o. lukavac - benzilpenicilinkalijum, benzilpenicilinprokain - prašak i rastvarač za rastvor za injekciju - 200000 i.j./1 bočica+ 600000 i.j./1 bočica - 1 bočica praška za rastvor za injekcijusadrži: 125 mg kalijum penicilina g što je ekvivalentno 200 000 i.j./bočici 600 mg prokain penicilina g što je ekvivalentno 600 000 i.j./bočici
rybrevant
janssen-cilag international n.v. - amivantamab - karcinom, ne-malih stanica pluća - antineoplastična sredstva - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
imuprin 50 mg/1 tableta film tableta
farmalogist allbix d.o.o. bijeljina - azatioprin - film tableta - 50 mg/1 tableta - 1 film tableta sadrži: 50 mg azatioprin